Literature DB >> 16902410

IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.

Günter Schneider1, Dieter Saur, Jens T Siveke, Ralph Fritsch, Florian R Greten, Roland M Schmid.   

Abstract

The IkappaB-inducing kinase (IKK) is composed of two catalytic subunits, IKKalpha and IKKbeta, and a regulatory subunit, IKKgamma. IKK-regulated signaling pathways are believed to promote the proliferation of normal cells as well as the aberrant proliferation of cancer cells. The molecular mechanisms linking the IKK signaling pathway components to the cell cycle machinery are not entirely understood. To study the function(s) of the catalytic subunits of the IKK complex, we used pancreatic cancer cells, with constitutive IKK activity. We show that the G1 phase of the cell cycle is specifically regulated by the IKKalpha subunit, which regulates the stability of the cyclin-dependent kinase inhibitor p27(Kip1). Increased p27(Kip1) protein levels following the transfection of IKKalpha-specific siRNAs are a result of the downregulation of the F-box protein S-phase kinase-associated protein 2 (skp2). Additionally, we demonstrate that IKKalpha signaling regulates the transcription of the skp2 gene by controlling the composition of a RelB-containing NF-kappaB complex. Together, this work defines a novel IKKalpha-regulated growth pathway involving the p52/RelB-dependent transcriptional regulation of the skp2 gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902410      PMCID: PMC1553200          DOI: 10.1038/sj.emboj.7601259

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Authors:  D C Guttridge; C Albanese; J Y Reuther; R G Pestell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Tumor-suppressive pathways in pancreatic carcinoma.

Authors:  E Rozenblum; M Schutte; M Goggins; S A Hahn; S Panzer; M Zahurak; S N Goodman; T A Sohn; R H Hruban; C J Yeo; S E Kern
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

Review 3.  Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time.

Authors:  Gioacchino Natoli; Simona Saccani; Daniela Bosisio; Ivan Marazzi
Journal:  Nat Immunol       Date:  2005-05       Impact factor: 25.606

4.  F-box protein Skp2: a novel transcriptional target of E2F.

Authors:  L Zhang; C Wang
Journal:  Oncogene       Date:  2006-04-27       Impact factor: 9.867

5.  Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation.

Authors:  Kyu-Jin Park; Venkatesh Krishnan; Bert W O'Malley; Yumi Yamamoto; Richard B Gaynor
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

Review 6.  Regulation of the cell cycle by SCF-type ubiquitin ligases.

Authors:  Keiichi I Nakayama; Keiko Nakayama
Journal:  Semin Cell Dev Biol       Date:  2005-06       Impact factor: 7.727

7.  Skp2-dependent degradation of p27kip1 is essential for cell cycle progression.

Authors:  Uta Kossatz; Nils Dietrich; Lars Zender; Jan Buer; Michael P Manns; Nisar P Malek
Journal:  Genes Dev       Date:  2004-11-01       Impact factor: 11.361

8.  Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression.

Authors:  Yumi Yamamoto; Udit N Verma; Shashi Prajapati; Youn-Tae Kwak; Richard B Gaynor
Journal:  Nature       Date:  2003-06-05       Impact factor: 49.962

9.  Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis.

Authors:  Lan Li; Bharat B Aggarwal; Shishir Shishodia; James Abbruzzese; Razelle Kurzrock
Journal:  Cancer       Date:  2004-11-15       Impact factor: 6.860

10.  Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation.

Authors:  Leonor M Sarmento; Hui Huang; Ana Limon; William Gordon; Jacquenilson Fernandes; Maria J Tavares; Lucio Miele; Angelo A Cardoso; Marie Classon; Nadia Carlesso
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

View more
  44 in total

Review 1.  Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma.

Authors:  Günter Schneider; Oliver H Krämer; Roland M Schmid; Dieter Saur
Journal:  J Gastrointest Cancer       Date:  2011-06

Review 2.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

3.  Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex.

Authors:  J Wu; S-W Lee; X Zhang; F Han; S-Y Kwan; X Yuan; W-L Yang; Y S Jeong; A H Rezaeian; Y Gao; Y-X Zeng; H-K Lin
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

4.  SUMO1 modification of NF-kappaB2/p100 is essential for stimuli-induced p100 phosphorylation and processing.

Authors:  Jaya Vatsyayan; Guoliang Qing; Gutian Xiao; Jing Hu
Journal:  EMBO Rep       Date:  2008-07-11       Impact factor: 8.807

5.  Nuclear factor κB2 p52 protein has a role in antiviral immunity through IκB kinase epsilon-dependent induction of Sp1 protein and interleukin 15.

Authors:  Sarah L Doyle; Kari Ann Shirey; Anne F McGettrick; Elaine F Kenny; Susan Carpenter; Brian E Caffrey; Siobhan Gargan; Susan R Quinn; Jorge H Caamaño; Paul Moynagh; Stefanie N Vogel; Luke A O'Neill
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

6.  Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1.

Authors:  Marianna Penzo; Paul E Massa; Eleonora Olivotto; Francesca Bianchi; Rosa Maria Borzi; Adedayo Hanidu; Xiang Li; Jun Li; Kenneth B Marcu
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

7.  The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway.

Authors:  Seongmi Park; Deepti B Ramnarain; Kimmo J Hatanpaa; Bruce E Mickey; Debabrata Saha; Ramasamy Paulmurugan; Christopher J Madden; Paul S Wright; Salman Bhai; M Aktar Ali; Krishna Puttaparthi; Wei Hu; Jeffrey L Elliott; Olaf Stuve; Amyn A Habib
Journal:  EMBO Rep       Date:  2008-06-20       Impact factor: 8.807

8.  Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?

Authors:  Peter Storz
Journal:  Expert Rev Anticancer Ther       Date:  2013-05       Impact factor: 4.512

9.  Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.

Authors:  Willie Wilson; Albert S Baldwin
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

10.  IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo.

Authors:  Melanie Scheibel; Bettina Klein; Heidrun Merkle; Manon Schulz; Ralph Fritsch; Florian R Greten; Melek C Arkan; Günter Schneider; Roland M Schmid
Journal:  J Exp Med       Date:  2010-10-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.